Phase 2
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Previous Treated Metastatic Non-small Cell Lung Cancer
Both
Previous Treated Metastatic Non-small Cell Lung Cancer
Trial Information
Inclusion Criteria:
- Cells pathologically diagnosed as histological or radical surgery or radiation
therapy is not possible stage IIIB and stage IV non-small-cell lung cancer patients
- second line
- ECOG 0～2
- Patients with normal liver function and renal function
Exclusion Criteria:
- Patients with severe acute infection requiring antibiotic therapy
- Patients who have received treatment in other areas of cancer within 5 years
- During pregnancy and lactation patients
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Overall response rate
Outcome Time Frame:
5 years
Safety Issue:
No
Authority:
South Korea: Institutional Review Board
Study ID:
2008-GIRBA-1739
NCT ID:
NCT01783834
Start Date:
February 2008
Completion Date:
December 2013
Related Keywords:
- Previous Treated Metastatic Non-small Cell Lung Cancer
- Pemetrexed
- Gefitinib
- iressa
- alimta
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
Name | Location |
|---|
